FMP
Embecta Corp.
EMBCV
NASDAQ
Inactive Equity
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
33.33 USD
-3.4299965 (-10.29%)
About
ceo
N/A
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.embecta.com
exchange
NASDAQ
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
1 Becton Drive
Phone
(201) 847-6800
Country
US
Employee
2,029
IPO Date
Mar 21, 2022
Summary
CIK
-
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
-
ISIN
-
Country
US
Price
33.33
Beta
0
Volume Avg.
3.48M
Market Cap
1.91B
Shares
-
52-Week
33.33-38.21
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://www.embecta.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EMBCV News
It looks like there's no news available.
